Lei, J., Rudolph, A., & Moysich, K. B. (2015). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).
Chicago-Zitierstil (17. Ausg.)Lei, Jieping, Anja Rudolph, und Kirsten B. Moysich. Assessment of Variation in Immunosuppressive Pathway Genes Reveals TGFBR2 to Be Associated with Prognosis of Estrogen Receptor-negative Breast Cancer After Chemotherapy. Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015.
MLA-Zitierstil (9. Ausg.)Lei, Jieping, et al. Assessment of Variation in Immunosuppressive Pathway Genes Reveals TGFBR2 to Be Associated with Prognosis of Estrogen Receptor-negative Breast Cancer After Chemotherapy. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015.